Investigational Site Number : 5540002

Christchurch 8013

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Chronic Kidney Diseases, Heart Failure, Type 2 Diabetes Mellitus

Studies at this site

• Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older — Completed
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early